Platelet Drug Trial in Coronary Disease Progression
Status:
Completed
Trial end date:
1982-12-01
Target enrollment:
Participant gender:
Summary
To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in
reducing the angiographic progression of coronary artery disease over a five-year period and
to test the predictive value of the platelet survival half-life in identifying patients with
more rapid progression of coronary disease and development of its complications.